- Supported exchanges /
- KQ /
- 018680.KQ
Seoul Pharma Co. Ltd (018680 KQ) stock market data APIs
Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally. The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer' disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V, as well as products for schizophrenia, vitamin supplement, obesity, tonic, and menopausal syndrome. The company also provides Ator for high blood pressure treatment; Flavel to treat stroke; Axated, a peptic ulcer medication; Crestin to treat hyperlipidemia; and Weltmin and Fendigene for the treatment of obesity. It also owns patents to orally dispersible films. The company was founded in 1976 and is headquartered in Cheongju-si, South Korea.
Seoul Pharma Co. Ltd Financial Data Overview
3470 | |
3450 | |
- | |
3545 | |
3450 | |
3130-6350 | |
40 458 M | |
11 659 K | |
42 277 M | |
23.317 | |
-0.017 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Seoul Pharma Co. Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 42 277 M
- EBITDA 6 197 M
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Seoul Pharma Co. Ltd Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get Seoul Pharma Co. Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: